Abstract
We conducted a decision analysis to assess and compare four algorithms for amplified Mycobacterium tuberculosis direct (MTD) testing of respiratory specimens in terms of cost-effectiveness. The most cost-effective strategy was one in which smear-positive specimens but not smear-negative specimens were diluted prior to MTD testing.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Cost-Benefit Analysis
-
Humans
-
Mycobacterium tuberculosis / genetics
-
Mycobacterium tuberculosis / isolation & purification*
-
Nucleic Acid Amplification Techniques / economics*
-
Nucleic Acid Amplification Techniques / methods*
-
Tuberculosis, Pulmonary / diagnosis*
-
Tuberculosis, Pulmonary / microbiology